Astrio Pharmaceuticals Private Limited
About Astrio Pharmaceuticals Private Limited
Data last updated:
Astrio Pharmaceuticals Private Limited is a private limited company based in Katrap, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 14 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2019PTC321185. Its GSTIN is 27AARCA9319C1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Santosh Bhila Borse and Kadambari Santosh Borse.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at B No 202 Gurudev Apt Katrap Kulgaon E, Maharashtra, India – 421503.
As per the financials filed for FY 2020, the company reported a revenue of ₹13.45 Lakh. For the same year it recorded a net loss of ₹17.54 Lakh (net margin -130.4%) and EBITDA of -₹17.33 Lakh (EBITDA margin -128.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Astrio Pharmaceuticals Private Limited's registered office is in Katrap, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB No 202 Gurudev Apt Katrap Kulgaon E, Maharashtra, India – 421503
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Astrio Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astrio Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Astrio Pharmaceuticals Private Limited, buy the company report.
Financials of Astrio Pharmaceuticals Private Limited
FY 2020 filings availableAstrio Pharmaceuticals Private Limited reported revenue of ₹13.45 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹13.45 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹17.33 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹17.54 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -128.9% | |
| Net Profit Margin | -130.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Astrio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Astrio Pharmaceuticals Private Limited
Astrio Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Bhila Borse | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
| Kadambari Santosh Borse | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
| Jayshree Santosh Borse | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Astrio Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nextone Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | 65.0% | Lucknow, Uttar Pradesh, India | |||
| Astrio Pharmaceuticals Private Limitedthis company | ₹13.45 Lakh (FY 2020) | -₹17.54 Lakh | -130.4% | Katrap, Maharashtra, India | ||
| Archimed Pharmaceuticals Private Limited | ₹13.4 Lakh (FY 2025) | -6.0% | Bareilly, Uttar Pradesh, India | |||
| Rightmed Pharmaceuticals Private Limited | ₹13.38 Lakh (FY 2020) | 239.0% | Perinthalmanna, Kerala, India | |||
| Pandora Pharmaceuticals Private Limited | ₹13.38 Lakh (FY 2025) | 7.0% | Shahdol, Madhya Pradesh, India |
To see the full peer comparison of Astrio Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Astrio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astrio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Astrio Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA9319C1ZH | Maharashtra | Active | 01 Mar 2019 |
To see the full GST registrations and return filing status of Astrio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Astrio Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jayshree Santosh Borse was appointed as Director on 14 Feb 2019.
Frequently asked questions
Astrio Pharmaceuticals is an active private limited company based in Katrap, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 14 February 2019 (7+ years old) and is registered under CIN U24230MH2019PTC321185.
Astrio Pharmaceuticals has 3 current directors:
- Santosh Bhila Borse - Director
- Kadambari Santosh Borse - Director
- Jayshree Santosh Borse - Director
The latest financial statements of Astrio Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Astrio Pharmaceuticals is 27AARCA9319C1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Astrio Pharmaceuticals is U24230MH2019PTC321185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astrio Pharmaceuticals was incorporated on 14 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Astrio Pharmaceuticals by revenue are Nextone Pharmaceuticals Private Limited, Archimed Pharmaceuticals Private Limited, Rightmed Pharmaceuticals Private Limited, Pandora Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jayshree Santosh Borse was appointed as Director on 14 Feb 2019. Kadambari Santosh Borse was appointed as Director on 14 Feb 2019. Santosh Bhila Borse was appointed as Director on 14 Feb 2019.
The registered office of Astrio Pharmaceuticals is at B No 202 Gurudev Apt Katrap Kulgaon E, Maharashtra, India – 421503.
Astrio Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Astrio Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.